Alcon announced it has acquired a majority interest in Aurion Biotech, a clinical-stage company developing advanced cell therapies to treat eye diseases. The announcement comes on the heels of recent news that Alcon intends to acquire LENSAR, which is anticipated to close in mid-to-late 2025. From surgical innovations to vision products, Alcon helps people see brilliantly. Learn about our company, careers, investor updates, and more. We welcome you at Alcon India, Your Vision is at the Heart of the Moments that Matter We aspire to lead the world in life-changing vision and eye care products because when you see brilliantly, you live brilliantly. This year, World Sight Day celebrates 25 years of advancing eye health—now it's time to invest in the Eye Care Professionals who tur
